Professionals of the Navarro Health Care Service (SNS-O), Navarra Services and Technologies (NASERTIC) and the Navarrabiomed Biomedical Research Center participate in three programs of the Convulsive Medicine Inpatient Infrastructure, marcha by the Salud Carlos III Institute (ISCIII).
These are three programs promoted within this initiative by Medicina Genómica, Medicina Predictiva, y Ciencia de Datos. The convocator to impulse IMPaCT constitutes the first step of the new Spanish Strategy for Personalized Medicine and amounts to a grant of 25.8 million euros. The ISCIII promotes these programs.
Allows, therefore, to advance in the implantation of the Personalized Medicine Precision in Spain, through the generation of genomic information generation, its integration with clinical information and ambient factors to improve the diagnosis, treatment and the ability to predict follow, in this way, a more safe, effective, preventive and predictive Medicine.
In this sense, it is proposed to create new massive sequencing centers, analyze data and biobanks and boost the development of new computing techniques, data processing and models that increase the exploitation and interoperability of existing systems of existence to support national health systems and the potential to participate in international projects.
Project financing
The first of the three, the Genome Medicine Program, will develop a network of five genomic analysis centers, one of them in Navarre. The Alliance Foral is establishing an alliance between the Navarra Hospital, Navarrabiomed and NASERTIC.
In addition, a group of clinical specialists will be established and, in total, the participation of 38 centers of all the autonomous communities will meet: 25 hospitals and 13 research and university centers, between them and the University of Navarre. The coordination will take place with the doctor Ángel Carracedo, from the Center for Biomedical Research in Rare Nursing Resources (CIBERER), with a funding of 7.24 million euros.
The Predictive Medicine Program comes as an end to the creation and maintenance of a public cohort (a group that forms part of a clinical study or study that is observed over a period of time), including clinical, epidemiological and biological data. This project will have a funding of 14 million euros.
The Science Data Program will create and maintain a system of recovery, integration and analysis of clinical and molecular data. Deel 47 47 institutions, with coverage in all the autonomous communities with accredited sanitary research institutes, and collaborating companies, foundations, universities and research centers, and counting on a funding of 4.55 million.